Catalyst Biosciences, Inc. (CBIO)
After hours:
| Previous close | 0.6768 |
| Open | 0.6800 |
| Bid | 0.6300 x 800 |
| Ask | 0.6600 x 900 |
| Day's range | 0.6300 - 0.6802 |
| 52-week range | 0.6300 - 7.5500 |
| Volume | |
| Avg. volume | 926,900 |
| Market cap | 20.102M |
| Beta (5Y monthly) | 1.82 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 20 Aug 2015 |
| 1y target est | N/A |
- GlobeNewswire
Catalyst Biosciences to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that members of its executive management team will participate in a fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference, being held November 29-December 2, 2021. The fireside chat will be available on-demand for registered attendees via the Piper Sandler conference site beginning Monday, November 22, 2021 at 10:00 am ET until the end of the conference
- GlobeNewswire
Catalyst Biosciences Announces Change in Corporate Strategy
Reports Third Quarter 2021 Operating & Financial ResultsCompany to discontinue MarzAA development; focus on developing its complement portfolio Management to host a call today at 8:30 am ET SOUTH SAN FRANCISCO, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced a strategic decision to halt the clinical development of MarzAA, report data to date, and seek a buyer for its hemophilia assets. Catalyst plans to focus its resources on its complement the
- GlobeNewswire
Catalyst Biosciences Announces CFI Variant Presentations at Two Upcoming Scientific Conferences
SOUTH SAN FRANCISCO, Calif., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that Grant Blouse, Ph.D., chief scientific officer, will present at two upcoming scientific conferences, the 5th Complement-based Drug Development Summit, being held October 26-28, 2021, and the American Society for Biochemistry and Molecular Biology’s (ASBMB) Serine Proteases in Pericellular Proteolysis and Signaling Virtual Meeting, being held October 28-30, 2021. Catalyst w
